Comparative safety profile of tyrosine kinase inhibitors in NSCLC: a network meta-analysis of hypertension and thrombotic risks

BackgroundThis study examines the risks of hypertension and thrombotic events in NSCLC patients treated with Tyrosine Kinase Inhibitors (TKIs).ObjectiveTo compare the safety profiles of TKIs used in NSCLC treatment, focusing on hypertension and thrombotic risks.MethodsA comprehensive search identifi...

全面介绍

书目详细资料

发表在:	Frontiers in Pharmacology
Main Authors:	Mingming Tan, Chenwei Pu, Zhenzhen Wang, Chengwei Jin
格式:	文件
语言:	英语
出版:	Frontiers Media S.A. 2025-01-01
主题:	non-small cell lung cancer tyrosine kinase inhibitors hypertension thrombotic events network meta-analysis NSCLC
在线阅读:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1491990/full